vs
Ameris Bancorp（ABCB）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Ameris Bancorp的2.0倍（$622.0M vs $314.4M），Ameris Bancorp净利率更高（35.1% vs 34.4%，领先0.7%），Ameris Bancorp同比增速更快（10.0% vs 4.8%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs 2.3%）
Ameris Bancorp是总部位于美国佐治亚州亚特兰大的银行控股企业，旗下子公司Ameris Bank在佐治亚、阿拉巴马、佛罗里达、北卡罗来纳、南卡罗来纳五州运营全服务网点，另在多州设有抵押贷款专属站点，同时面向个人及企业客户提供便捷的线上及移动银行服务。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
ABCB vs RPRX — 直观对比
营收规模更大
RPRX
是对方的2.0倍
$314.4M
营收增速更快
ABCB
高出5.2%
4.8%
净利率更高
ABCB
高出0.7%
34.4%
两年增速更快
RPRX
近两年复合增速
2.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $314.4M | $622.0M |
| 净利润 | $110.5M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | — | 62.4% |
| 净利率 | 35.1% | 34.4% |
| 营收同比 | 10.0% | 4.8% |
| 净利润同比 | — | 2.9% |
| 每股收益（稀释后） | $1.63 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABCBRPRX
| Q1 26 | $314.4M | — | ||
| Q4 25 | $307.1M | $622.0M | ||
| Q3 25 | $314.2M | $609.3M | ||
| Q2 25 | $300.7M | $578.7M | ||
| Q1 25 | $285.9M | $568.2M | ||
| Q4 24 | $290.8M | $593.6M | ||
| Q3 24 | $283.8M | $564.7M | ||
| Q2 24 | $300.6M | $537.3M |
净利润ABCBRPRX
| Q1 26 | $110.5M | — | ||
| Q4 25 | $108.4M | $214.2M | ||
| Q3 25 | $106.0M | $288.2M | ||
| Q2 25 | $109.8M | $30.2M | ||
| Q1 25 | $87.9M | $238.3M | ||
| Q4 24 | $94.4M | $208.2M | ||
| Q3 24 | $99.2M | $544.0M | ||
| Q2 24 | $90.8M | $102.0M |
营业利润率ABCBRPRX
| Q1 26 | — | — | ||
| Q4 25 | 45.9% | 62.4% | ||
| Q3 25 | 43.6% | 70.1% | ||
| Q2 25 | 47.4% | 36.3% | ||
| Q1 25 | 39.5% | 94.0% | ||
| Q4 24 | 43.3% | 60.9% | ||
| Q3 24 | 44.4% | — | ||
| Q2 24 | 42.1% | 50.2% |
净利率ABCBRPRX
| Q1 26 | 35.1% | — | ||
| Q4 25 | 44.2% | 34.4% | ||
| Q3 25 | 33.7% | 47.3% | ||
| Q2 25 | 36.5% | 5.2% | ||
| Q1 25 | 30.8% | 41.9% | ||
| Q4 24 | 42.5% | 35.1% | ||
| Q3 24 | 35.0% | 96.3% | ||
| Q2 24 | 30.2% | 19.0% |
每股收益（稀释后）ABCBRPRX
| Q1 26 | $1.63 | — | ||
| Q4 25 | $1.59 | $0.49 | ||
| Q3 25 | $1.54 | $0.67 | ||
| Q2 25 | $1.60 | $0.07 | ||
| Q1 25 | $1.27 | $0.55 | ||
| Q4 24 | $1.35 | $0.46 | ||
| Q3 24 | $1.44 | $1.21 | ||
| Q2 24 | $1.32 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $4.1B | $9.7B |
| 总资产 | $28.1B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资ABCBRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | $618.7M | ||
| Q3 25 | — | $938.9M | ||
| Q2 25 | — | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $929.0M | ||
| Q3 24 | — | $950.1M | ||
| Q2 24 | — | $1.8B |
总债务ABCBRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B |
股东权益ABCBRPRX
| Q1 26 | $4.1B | — | ||
| Q4 25 | $4.1B | $9.7B | ||
| Q3 25 | $4.0B | $9.6B | ||
| Q2 25 | $3.9B | $9.5B | ||
| Q1 25 | $3.8B | $9.8B | ||
| Q4 24 | $3.8B | $10.3B | ||
| Q3 24 | $3.7B | $10.3B | ||
| Q2 24 | $3.6B | $9.8B |
总资产ABCBRPRX
| Q1 26 | $28.1B | — | ||
| Q4 25 | $27.5B | $19.6B | ||
| Q3 25 | $27.1B | $19.3B | ||
| Q2 25 | $26.7B | $18.3B | ||
| Q1 25 | $26.5B | $17.6B | ||
| Q4 24 | $26.3B | $18.2B | ||
| Q3 24 | $26.4B | $18.0B | ||
| Q2 24 | $26.5B | $17.7B |
负债/权益比ABCBRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ABCBRPRX
| Q1 26 | — | — | ||
| Q4 25 | $390.2M | $827.1M | ||
| Q3 25 | $104.9M | $702.6M | ||
| Q2 25 | $61.4M | $364.0M | ||
| Q1 25 | $116.9M | $596.1M | ||
| Q4 24 | $154.2M | $742.5M | ||
| Q3 24 | $102.2M | $703.6M | ||
| Q2 24 | $-97.1M | $658.2M |
自由现金流ABCBRPRX
| Q1 26 | — | — | ||
| Q4 25 | $369.6M | — | ||
| Q3 25 | $100.5M | — | ||
| Q2 25 | $53.7M | — | ||
| Q1 25 | $114.2M | — | ||
| Q4 24 | $140.7M | — | ||
| Q3 24 | $99.8M | — | ||
| Q2 24 | $-100.3M | — |
自由现金流率ABCBRPRX
| Q1 26 | — | — | ||
| Q4 25 | 120.4% | — | ||
| Q3 25 | 32.0% | — | ||
| Q2 25 | 17.9% | — | ||
| Q1 25 | 39.9% | — | ||
| Q4 24 | 48.4% | — | ||
| Q3 24 | 35.2% | — | ||
| Q2 24 | -33.4% | — |
资本支出强度ABCBRPRX
| Q1 26 | — | — | ||
| Q4 25 | 6.7% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 4.6% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 1.1% | — |
现金转化率ABCBRPRX
| Q1 26 | — | — | ||
| Q4 25 | 3.60× | 3.86× | ||
| Q3 25 | 0.99× | 2.44× | ||
| Q2 25 | 0.56× | 12.06× | ||
| Q1 25 | 1.33× | 2.50× | ||
| Q4 24 | 1.63× | 3.57× | ||
| Q3 24 | 1.03× | 1.29× | ||
| Q2 24 | -1.07× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABCB
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
